• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, INC. VITEK® 2 AST-P654 TEST KIT; AST-P654 TEST KIT 20 CARDS - 421912

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, INC. VITEK® 2 AST-P654 TEST KIT; AST-P654 TEST KIT 20 CARDS - 421912 Back to Search Results
Catalog Number 421912
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer in (b)(6) notified biomérieux of a false positive cefoxitin screen (oxsf) result for a staphylococcus aureus strain in association with the vitek® 2 ast-p654 test kit (ref.421912, lot 8041158403).The customer stated the associated oxacillin result was susceptible, modified to resistant by aes (advanced expert system¿).Alternate methods (pcr, (b)(6) and (b)(6) screening agar ) were negative.The customer also stated that of 58 staphylococcus aureus isolates tested this week, nine (9) provided false positive oxsf results.Of the nine (9) claims, testing evidence was provided by the customer for only six (6) of the claims, including this complaint.The other five (5) are being documented in separate complaint records.There is no indication or report from the laboratory that the discrepant result led to any adverse event related to the patient's state of health.
 
Manufacturer Narrative
An internal investigation was preformed following the notification of a false positive cefoxitin screen result for a patient staphylococcus aureus isolate in association with the vitek® 2 ast-p654 test kit (ref.421912, lot 8041158403).A review of complaints associated with the vitek® 2 ast-p653 lot 8041158403 did not identify a trend for this card lot.Submittal of the isolate is required in order to confirm a vitek® 2 discrepancy compared to the reference method.No investigational testing could be performed.The vitek® 20 ast-p654 lot 8041158403 met final qc release criteria.The lot passed qc performance testing for the cefoxitin screen.See section h10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK® 2 AST-P654 TEST KIT
Type of Device
AST-P654 TEST KIT 20 CARDS - 421912
Manufacturer (Section D)
BIOMERIEUX, INC.
595 anglum road
hazelwood MO 63042
MDR Report Key9526925
MDR Text Key219778657
Report Number1950204-2019-00335
Device Sequence Number1
Product Code LON
Combination Product (y/n)N
PMA/PMN Number
K053097
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 03/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/27/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/27/2021
Device Catalogue Number421912
Device Lot Number8041158403
Was Device Available for Evaluation? No
Date Manufacturer Received02/11/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-